Novel 6-Month Treatment for Drug-Resistant Tuberculosis, United States

The US Food and Drug Administration approved a 6-month regimen of pretomanid, bedaquiline, and linezolid for extensively drug-resistant or multidrug-intolerant tuberculosis after a trial in South Africa demonstrated 90% effectiveness 6 months posttreatment. We report on a patient who completed the r...

Descripción completa

Detalles Bibliográficos
Autores principales: Haley, Connie A., Macias, Patricia, Jasuja, Supriya, Jones, Betsy A., Rowlinson, Marie-Claire, Jaimon, Roshni, Onderko, Pennelyn, Darnall, Elaine, Gomez, Maria E., Peloquin, Charles, Ashkin, David, Goswami, Neela D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2021
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7774582/
https://www.ncbi.nlm.nih.gov/pubmed/33227229
http://dx.doi.org/10.3201/eid2701.203766

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7774582/
https://www.ncbi.nlm.nih.gov/pubmed/33227229
http://dx.doi.org/10.3201/eid2701.203766

Ejemplares similares